NEW YORK/PARIS, May 19 (Reuters) - The U.S. Food and Drug Administration reviewers have linked Sanofi-Aventis SA’s antibiotic Ketek to 12 cases of liver failure, including four deaths, and is now recommending the company put a warning label on the drug, the Wall Street Journal said on Friday.
